Clinical Trial Update: Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of liposomal doxorubicin, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer has been terminated. The update notes trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• HERCEPTIN (trastuzumab)
• Taxotere (docetaxel)

Snippet

Sponsor: Laurence J.C. van Warmerdam | Conditions: Breast Cancer, Neoplasm Metastasis | Phase 2 | Status: TERMINATED